AMY AN: Open Payments
NPI 1740518190 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$769 in 26 payments from 8 companies in 2025. Trend: 2023 $1,584 · 2024 $749 · 2025 $769
Food & beverage: $769
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $274 |
| ABBVIE INC. | 9 | $252 |
| COLOPLAST CORP | 3 | $59 |
| Astellas Pharma US Inc | 2 | $57 |
| 180 Medical, Inc. | 2 | $57 |
| FEMSelect Inc. | 1 | $34 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $19 |
| Becton, Dickinson and Company | 1 | $17 |
Products named: GEMTESA, BOTOX, Veozah, GENTLECATH, Luja Coude, ENPLACE, Restorelle, PureWick Female External Catheter.
Industry payments across AZ — which companies pay providers there.
